THE CHEMO SERO THERAPEUTIC RES INSTITUTE has a total of 26 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are FIGENE LLC, THE CHEMO-SERO-THERAPEUTIC RES INST and IDM IMMUNO DESIGNED MOLECULES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Brazil | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Mexico | 2 | |
#7 | Philippines | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Australia | 1 | |
#10 | China | 1 | |
#11 | Israel | 1 | |
#12 | Singapore | 1 | |
#13 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Medical technology | |
#5 | Foods and drinks | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Peptides | |
#6 | Object sterilising | |
#7 | Implantable devices | |
#8 | Enzymes | |
#9 | Unspecified technologies | |
#10 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Abe Motoharu | 7 |
#2 | Shinmura Yasuhiko | 5 |
#3 | Sonoda Kengo | 5 |
#4 | Hayashi Yasuhisa | 5 |
#5 | Maruno Shinichi | 5 |
#6 | Yamaori Susumu | 5 |
#7 | Fukuda Aki | 5 |
#8 | Yoshimura Masaya | 5 |
#9 | Komura Fusae | 5 |
#10 | Takagi Shota | 5 |
Publication | Filing date | Title |
---|---|---|
WO2018117143A1 | Chromatographic method for collecting blood coagulation factor vii with high yield | |
CA3010049A1 | Vaccine containing immobilized virus particles | |
MX2018006500A | Live virus having a bank of dengue virus attenuated strains, and a dengue vaccine containing same as antigens. | |
EP2471915A1 | Modified peptide vaccine derived from influenza m2 | |
EP2363469A1 | Process for preparing inclusion body-forming protein |